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Abstract
Episodic drug use and binge drinking are associated with HIV risk among substance-using men 
who have sex with men (SUMSM), yet no evidence-based interventions exist for these men. We 
adapted personalized cognitive counseling (PCC) to address self-justifications for high-risk sex 
among HIV-negative, episodic SUMSM, then randomized men to PCC (n = 162) with HIV testing 
or control (n = 164) with HIV testing alone. No significant between-group differences were found 
in the three primary study outcomes: number of unprotected anal intercourse events (UAI), 
number of UAI partners, and UAI with three most recent non-primary partners. In a planned 
subgroup analysis of non-substance dependent men, there were significant reductions in UAI with 
most recent non-primary partners among PCC participants (RR = 0.56; 95 %CI 0.34–0.92; P = 
0.02). We did not find evidence that PCC reduced sexual risk behaviors overall, but observed 
significant reductions in UAI events among non-dependent SUMSM. PCC may be beneficial 
among SUMSM screening negative for substance dependence.
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Introduction
Although men who have sex with men (MSM) represent 4 % of the U.S. male population 
[1], they accounted for 78 % of all new HIV infections among males and 63 % of all new 
infections in the United States in 2011 [2]. In San Francisco, MSM accounted for 82 % of 
new HIV infections in 2011 [3]. Among MSM nationally [4], and in San Francisco [3], HIV 
prevalence is 3–6 times as high among blacks/African Americans and Latinos compared to 
whites. Drug and alcohol (“substance”) use occurs disproportionately among MSM [5–8], 
and substantially increases HIV risk when occurring just before or during sex [9–11]. Across 
MSM populations, methamphetamine, amyl nitrate (poppers), cocaine, and heavy alcohol 
use are the substances most consistently associated with high-risk behaviors and disease 
incidence, including unprotected anal intercourse (UAI), high numbers of sexual partners, 
Coffin et al. Page 2













HIV seroconversion, sexually transmitted infections, and condom slippage or breakage [9–
19]. These substances have several effects, including increased libido, sexual confidence, 
sense of invulnerability, expectancies of cognitive escape and sexual satisfaction, and 
impaired judgment. Each of these effects can be associated with high-risk sexual practices 
[20–24].
The relationship between substance use and HIV risk is further complicated by differences 
in frequency of use and polysubstance use. HIV transmission risk is positively associated 
with severity and frequency of substance use and related to concomitant use of multiple 
substances [25]. Many substance-using MSM (SUMSM) use substances recreationally and 
less than weekly (i.e., “episodically”); however, few use only one substance [25]. In the 
National HIV Behavioral Surveillance study, 69–86 % of SUMSM reported less than 
weekly substance use [26–29]. In San Francisco, less than weekly use was reported by 76 % 
of methamphetamine users, 79 % of poppers users, 86 % of cocaine users, and 62 % of 
crack users [30]. In a study of circuit parties, SUMSM reported a median of 3.5 drugs used 
during circuit party weekends, but fewer than 5 % reported use of any illicit substances 
during non-event weekends [12]. Many episodic SUMSM report sex and substance use 
“always” or “often” go together, and qualitative studies show that MSM use substances 
specifically to perform sexual acts [21, 31–33]. Whereas the heaviest substance users carry 
the greatest individual risk for HIV transmission, the larger population of episodic users may 
present a greater population-level risk for transmission. Moreover, as episodic SUMSM may 
not identify a problem with their use and may not require or access intensive therapy, 
tailored behavioral interventions may be effective in reducing sex and drug risk.
Nine HIV prevention interventions were classified by the Centers for Disease Control and 
Prevention (CDC) as demonstrating best-evidence of intervention efficacy in reducing HIV-
related risk behaviors among MSM [34]. However, none of these interventions address co-
occurring substance use and sexual risk associated with HIV transmission. Given the high 
rate of episodic substance use among MSM, its link with sexual risk, and paucity of proven 
interventions for episodic SUMSM, it is important to adapt existing interventions for this 
high-risk population [35]. The personalized cognitive counseling (PCC) intervention [36], 
which CDC has identified as a “best evidence” intervention, was adapted for episodic 
SUMSM because it demonstrated a strong and sustained effect in reducing number of UAI 
episodes with partners of HIV-positive or unknown serostatus in two randomized trials [37, 
38]. PCC involves a brief counseling session, and is acceptable in a general population of 
MSM [37, 38] and among MSM of color [39]. PCC is predicated on the hypothesis that 
many HIV-negative MSM who take risks do so despite knowing the potential for HIV 
infection.
The three-phase process used to adapt PCC for episodic SUMSM is described elsewhere 
[40]. To briefly summarize, phase 1 involved in-depth interviews with 20 episodic SUMSM 
to identify and abstract relevant self-justifications for unprotected anal intercourse and 
concurrent substance use. Self-justifications were compared to self-justifications from the 
original PCC instrument to determine which of the original self-justifications to retain and 
which new items to add. Criteria for the creation of new items included linkage of alcohol 
and/or other drug use to UAI, frequency of theme occurrence across participants, and topics 
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that would resonate for a wide range of MSM (e.g. transmission risk calculus). The adapted 
self-justification elicitation instrument (SJEI) included 17 items retained from the original 
PCC SJEI and 31 newly developed items. Nine themes related to self-justifications emerged 
from the in-depth interviews: [1] substance use as facilitator of risk, [2] transmission risk 
calculus, [3] assumptions regarding partner’s HIV status, [4] cognitive escape, [5] sensation 
seeking/spontaneity, [6] condom-related issues, [7] opportunities for sex, [8] expectations or 
obligations for unprotected sex, and [9] feelings of invincibility. Phase 2 involved pre-
testing the adapted SJEI with 19 episodic SUMSM to determine relevance and 
representativeness of self-justification items. During this phase we also elicited participant 
comments about the adapted SJEI. Participants appreciated the informal language used as 
well as the comprehensiveness and utility of the instrument. Phase 3 of the adaptation 
process involved pilot testing the complete PCC intervention session with 20 episodic 
SUMSM to determine feasibility and acceptability. Participants filled out the SJEI and then 
met with a counselor for a PCC session. Afterwards, participants were invited to critique the 
SJEI and the counseling process. Participants in the pilot test phase reported similar positive 
feedback as those in the pre-test phase. Feedback from pretesting of the adapted SJEI and 
pilot testing was incorporated in the final adapted PCC.
In this paper, we report findings on the efficacy of the adapted PCC intervention for 
reducing HIV-related sexual risk behaviors among ethnically diverse, HIV-negative, 
episodic SUMSM. We hypothesized that episodic SUMSM who receive the adapted PCC 
and rapid HIV testing would report greater reductions in number of unprotected anal 
intercourse (UAI) events, number of unprotected UAI partners, and number of UAI events 
with three most recent non-primary partners than men receiving rapid HIV testing only.
Methods
Between May 2010 and May 2012, we recruited episodic SUMSM who engaged in sexual 
activity that increased their risk of HIV acquisition, specifically high-risk UAI while under 
the influence of alcohol and other drugs. The definition for “episodic” substance use was 
derived from prior research studies of MSM conducted in San Francisco [11, 41]. 
Recruitment involved street outreach at community venues in San Francisco, including 
outside of bars, clubs, grocery stores, gyms, and other venues frequented by MSM. To 
recruit a racially and ethnically diverse sample of episodic SUMSM, recruitment also 
occurred at community-based organizations serving African American, Latino, and Asian 
and Pacific Islander MSM. For venue-based recruitment, study recruiters informed potential 
participants of the study, emphasized that participation was voluntary, and provided flyers 
describing the study.
Potential participants completed a brief telephone screening to assess initial eligibility and, if 
eligible, were scheduled for in-person re-screening visits. Eligible participants: (a) reported 
UAI with another man while under the influence of at least one or any combination of the 
following substances: methamphetamine, poppers, crack or powder cocaine, or alcohol if 
binge drinking (five or more drinks) within 2 h before or during sex within the past 6 
months; (b) identified as male; (c) were HIV-negative or unknown serostatus by self-report; 
(d) were willing and able to participate in an intervention that addresses episodic substance 
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use and sexual risk behavior; (e) were not currently in substance use treatment, a self-help 
program, an HIV prevention study, or receiving prophylaxis treatment; (f) had not injected 
any substances in prior 6 months; (g) were 18 years of age or older; (h) were planning to 
remain in the San Francisco Bay Area for the duration of study activities; and (i) were able 
to speak, read, and understand English. Men were ineligible if they reported UAI during the 
past 6 months with only one primary partner; and reported weekly or more use of any of the 
targeted substances in the prior 3 months or, for alcohol, more than an average of three 
alcoholic drinks daily or binge drinking more than twice weekly. Men who reported use of 
“club drugs” such as ecstasy, ketamine, and GHB were not excluded from the study as long 
as they also reported use of the target substances. Ineligible participants were provided 
information about community referrals for more intensive substance use treatment. All 
participants provided informed consent to participate in the study and the protocol was 
approved by the University of California Committee on Human Research. The study is 
registered on www.clinicaltrials.gov (NCT01279044).
Baseline and Follow-up Visits
During the initial study visit, all eligible participants were rescreened for eligibility, 
provided informed consent, and completed a baseline assessment using audio computer-
assisted self-interview (ACASI) technology to standardize data collection and minimize 
reporting bias [42]. Participants were informed that they could be randomized to the PCC 
arm or the control arm (the exact language in the informed consent document was “Half the 
men enrolled in this study will be selected by a computer to meet with a counselor during 
their visit. You will have an equal chance of being placed in this group or in the group that 
does not meet with a counselor.”). Eligible participants were then randomly assigned to 
either the PCC intervention arm or control arm (i.e., rapid HIV testing and information 
describing HIV test procedures and transmission). A one-to-one random allocation sequence 
was generated using a SAS computer program; allocations were in a fixed-block size of 
four. To ensure balanced study arms in terms of race/ethnicity and age, randomization was 
stratified into four groups: [1] African American participants age 25 and under, [2] African 
Americans over 25 years old, [3] Non-African American participants age 25 and under, [4] 
Non-African American participants over 25 years old. Staff members who had no contact 
with study participants enclosed and sealed treatment allocation cards in sequentially 
numbered opaque envelopes to correspond with the randomization sequence. As a 
participant was enrolled, the envelope that corresponded with their sequence was opened to 
reveal their randomized treatment condition.
All participants seen at baseline and at 3- and 6-month follow-up visits received a rapid HIV 
test following CDC’s guidelines for HIV testing in health care settings [43]. In both study 
arms, persons testing positive by the rapid test received a confirmatory Western Blot assay 
performed by the CLIA-certified laboratory at the San Francisco Department of Public 
Health. Newly diagnosed participants received counseling about their HIV positive antibody 
test, the importance of mobilizing support, and risk-reduction counseling. Referrals were 
made for services and health care, including San Francisco clinics specializing in treating 
new HIV cases, and assistance provided to make appointments as needed. All project 
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counselors were trained and certified in HIV testing and counseling, and attended refresher 
courses every 6–12 months.
Participants received reminder phone calls and/or emails prior to each study visit, and were 
remunerated $35 for the baseline assessment, $40 for the 3-month assessment, and $50 for 
the 6-month assessment. All study procedures were conducted in private counseling rooms 
at the San Francisco Department of Public Health.
Intervention
PCC is based on the hypothesis that many MSM who take risks do so despite knowing the 
potential for HIV infection, and is guided by Bandura’s theory of self-regulation [44, 45], 
DiClemente and Prochaska’s stages of behavior change [46, 47], and Gold and colleagues’ 
concept of self-justifications for high-risk sexual behaviors among MSM [48]. The 30–50-
min PCC session involved five key counselor-guided activities and was adapted for episodic 
substance using MSM [40]. In each PCC session the participant recalled a recent memorable 
encounter of UAI with another man of unknown or serodiscordant HIV status and used that 
salient event to complete a paper SJEI with pre-worded statements [40] to elicit the specific 
self-justifications used to minimize the known sexual risk that permitted him to proceed with 
UAI and prepare for a detailed discussion of the event. The counselor encouraged the 
participant to identify and express any thoughts, feelings or attitudes that may have led to 
the high-risk sexual encounter and aided the participant in clarifying which of the selected 
self-justifications led to risky behavior. The participant then explored strategies to avoid 
similar high-risk situations in the future, including reframing self-justifications to clarify the 
reality of risk. The counseling allowed participants to re-examine the function of self-
justifications they utilized when making a decision to engage in high-risk sex, reappraise the 
level of risk that occurred, and modify self-justifications or generate alternative self-
statements that might reduce sexual risk in the future [37, 38]. Counseling sessions were 
taped and selected sessions were reviewed for fidelity.
After completing their 3-month follow-up assessment, intervention participants received one 
of three types of booster counseling sessions tailored to their interim level of risk: [1] if the 
participant reported UAI with a different partner than at baseline, he completed the SJEI and 
received PCC; [2] if the participant reported UAI with the same partner as at baseline, he did 
not receive the SJEI and PCC but received counseling regarding explicit communication 
about HIV status and risk that occurred between participant and partner to identify 
assumptions about risk and efforts the participant could make to reduce his HIV risk in the 
current relationship; or [3] if the participant reported only protected anal intercourse or no 
anal intercourse in the past 3 months, he received neither the SJEI nor PCC but a general 
counseling session focused on reasons for protected or no anal intercourse, who initiated 
protection, feelings/thoughts around reduced sexual risk, and ways to continue reducing 
sexual risk.
Table 1 includes the most common self-justifications endorsed by PCC participants at 
baseline and 3-month booster sessions with within-person concordance for each self-
justification between the two visits. We collected no qualitative or quantitative data around 
Coffin et al. Page 6













self-justification stability/fluidity to support any hypothesis as to the reason for rates of 
concordance.
Measures
Sexual risk behavior measures—Measures included number of sex partners and 
number of unprotected receptive and insertive anal intercourse events in the prior 3 months. 
UAI events were asked for primary and three most recent non-primary partners [11]. A 
priori primary study outcomes include number of UAI events, number of UAI partners, and 
number of UAI events with three most recent non-primary partners. Secondary outcomes 
included number of serodiscordant unprotected anal intercourse (SDUAI) events with non-
primary partners (i.e., the outcome used in the original PCC efficacy studies [37, 38]), 
number of condom-protected anal intercourse events, and number of insertive and receptive 
UAI events.
Substance dependence—Self-reported data on the five-item severity of dependence 
scale (SDS) [49], a validated measure of symptoms of substance dependence, was collected 
for each of the target substances: methamphetamine, poppers, cocaine and alcohol. 
Calculated SDS scores had high internal validity and consistency; Cronbach’s alphas for 
SDS scores on methamphetamine, poppers, cocaine and alcohol were 0.80, 0.73, 0.85 and 
0.86, respectively. In previously published validation studies, an SDS score of 4 or more 
was indicative of methamphetamine dependence [50], and an SDS score of 3 or more was 
indicative of dependence on cocaine and alcohol [51, 52]. We did not find a published SDS 
cut-off for poppers so poppers use dependence was classified as a SDS score of 3 or more, 
the most common cut-off among our study’s other target substances [51, 52].
Statistical Analysis
To calculate sample size, we assumed (a) a post-randomization relative reduction in 
outcomes of 10 % among controls due to cohort effects; (b) that numbers of UAI/ SDUAI 
events as well as partners would be strongly correlated within person [11]; and (c) that 90 % 
of the sample would attend both follow-up visits. Under these assumptions, a sample of 
300–326 participants provided 80 % power to detect relative reductions of 24–38 % in these 
outcomes, depending on within-subject correlations.
Intention-to-treat (ITT) analyses for primary and secondary outcomes were conducted 
according to participants’ random allocation (PCC = 162; control = 164), without regard to 
adherence to study procedures, and based on all observed study data. We did not impute 
missing outcomes; less than 5 % of data was missing due to missed visits and study drop-
out. We used generalized estimating equations (GEE) models to evaluate group-specific 
linear trends outcomes across the three study visits, with robust standard errors to account 
for within-subject correlation as well as potential over-dispersion of count outcomes. Binary 
and count outcomes were examined using Poisson and negative binomial models, 
respectively. In all models, the effect of the intervention was estimated by the interaction 
between the treatment assignment indicator and a linear term in time. The exponentiated 
coefficient for interaction is interpretable as the ratio of the intervention and control rates of 
change in the mean value of the outcome, or rate ratio (RR). The linearity assumption was 
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verified for all models. We conducted planned sub-group analyses stratified by any 
substance dependence for methamphetamine, poppers, cocaine and alcohol at baseline, as 
measured by the SDS. We also conducted post hoc subgroup analyses stratified by race/
ethnicity, both overall and restricted to the non-dependent group.
Results
Sample Characteristics and Retention
Of 2,649 potential participants screened, 431 (16.3 %) met eligibility criteria. Among 2,218 
ineligible participants, 32 % reported no substance use during UAI, 29 % reported no UAI 
with non-primary partner, and 16 % reported no UAI, all during the past 6 months. There 
were no significant differences between eligible and ineligible participants by age (z = 
−0.30; P = 0.76) or race/ethnicity (χ2 = 3.62; P = 0.46); eligible participants were more 
likely to have had an HIV test during the past year than ineligible participants (χ2 = 21.15; P 
< 0.001). Among eligible participants, 326 (75.4 %) agreed to participate and were enrolled 
in the study. Overall, 96 % of participants completed 3- and 6-month follow-up assessments; 
reasons for attrition are provided in Fig. 1. There were no significant differences in retention 
by study arm (PCC 94 % and control 98 %; χ2 = 2.76; P = 0.10). There were no study-
related adverse events.
There were no significant differences between the two study arms on baseline 
demographics, HIV testing, and substance use (Table 2). The mean age was 33.6 years; 47 
% were white and 53 % non-white including 26 % Latino/Hispanic, 11 % Asian and Pacific 
Islander, 10 % black/African American, and 6 % mixed/other race. The majority (83 %) was 
born in the US, 71 % completed some college or had college degree, and 71 % earned over 
$20,000 per year. A majority of participants (92 %) reported having an HIV test during the 
past year, 63 % had a regular health provider, and 68 % had either private or public health 
insurance. Two participants tested HIV-positive at the baseline visit, three at the 3-month 
visit, and none at the 6-month visit (all were included in analysis per ITT).
Efficacy Analyses
There were no statistically significant differences in baseline sexual risk behaviors between 
study arms. In intention-to-treat (ITT) analyses, no significant intervention effects were 
observed for the three primary outcomes, including total number of UAI events, number of 
UAI partners, and number of UAI events with three most recent non-primary partners; nor 
for secondary outcomes including number of SDUAI events, condom-protected anal 
intercourse events, and number of insertive UAI events (Table 3). PCC participants reported 
borderline significantly greater declines in number of receptive UAI events over the study 
period than control participants (RR = 0.57; 95 %CI 0.33–1.01; P = 0.052).
Sub-group Analyses
A total of 138 participants were classified as substance dependent based on SDS scores, 
including 7 for methamphetamine, 12 for poppers, 21 for cocaine, and 122 for alcohol. 
Participants dependent on only one substance included 2 for methamphetamine, 3 for 
poppers, 10 for cocaine, and 103 for alcohol. There were no significant intervention effects 
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on primary or secondary outcomes among these substance-dependent SUMSM. For 
participants not dependent on any target substance, PCC participants (N = 93) reported 
significantly greater reductions in number of UAI events with three most recent non-primary 
partners than control participants (N = 93) (RR = 0.56; 95 %CI 0.34–0.92; P = 0.02; Fig. 2). 
However, there were no significant intervention effects on total number of UAI events (RR 
= 1.61; 95 %CI 0.79–3.28; P = 0.19), total number of UAI partners (RR = 1.09; 95 %CI 
0.64–1.86; P = 0.76) or number of SDUAI events (RR = 0.57; 95 %CI 0.26–1.22; P = 0.15).
In subgroup analyses of SUMSM of color (N = 79 in PCC, N = 92 in control), we did not 
observe significant intervention effects on the primary outcomes. However, among non-
substance dependent SUMSM of color (N = 44 in PCC, N = 51 in control), we observed 
significant intervention effects in total number of UAI events (RR = 0.41; 95 %CI 0.18–
0.95; P = 0.04) and UAI events with three most-recent non-primary partners (RR = 0.37; 95 
%CI 0.16–0.87; P = 0.02).
Discussion
In this randomized controlled trial, we did not find evidence that the adapted PCC 
intervention was efficacious in reducing sexual risk behaviors among the full cohort of HIV-
negative, episodic SUMSM, but did identify a reduction in one primary sexual risk behavior 
outcome among participants screening as non-dependent on target substances. The 
significant reduction in number of UAI events with three most recent non-primary partners 
reflects a moderate effect size, which may correspond with clinically significant reductions 
in HIV risk among non-dependent, episodic SUMSM. In the full cohort, PCC participants 
reported a borderline significant trend for greater declines in number of receptive UAI 
events over the study period than control participants. These findings suggest that the 
adapted PCC may benefit SUMSM who screen negative for substance dependence by SDS.
Among non-substance dependent men of color, we observed statistically significant 
reductions in total number of UAI events and number of UAI events with three most recent 
non-primary partners. Although this analysis was post hoc, the result suggests that PCC may 
be particularly efficacious among that subgroup. This finding is consistent with a secondary 
analysis of a prior efficacy trial among MSM of color in which PCC participants reported 
greater reductions in mean UAI episodes than control participants [39]. Although the sub-
group analysis is limited to a small sample of non-dependent SUMSM of color, these 
findings are important given the lack of efficacious interventions for MSM of color [53, 54] 
and high HIV incidence in this population [4]. A subsequent evaluation of PCC delivered to 
SUMSM of color may be an important next step to conclusively validate these findings.
The adapted PCC was intended for episodic SUMSM and involved a brief counseling 
session plus rapid HIV testing. However, given the degree of substance use reported by 
participants, it appears some participants were substance-dependent and we would not 
expect the intervention to affect sexual risk behaviors among substance-dependent MSM. 
Nonetheless, 42 % of enrolled subjects screened positive for substance dependence, 88 % of 
whom reported symptoms of alcohol dependence. In an analysis of this study’s screener 
data, we found strong evidence of a dose-response relationship between frequency of 
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substance use and HIV-risk; with more severe substance use associated with greater odds of 
HIV risk [25]. These findings suggest that a sensitive screen for dependence, such as the 
SDS, may be necessary if this intervention is to be implemented in HIV prevention practice. 
MSM reporting substance use dependence symptoms should probably be directed to more 
intensive substance use services. Treating substance dependence among SUMSM would 
likely elevate the efficacy of HIV prevention interventions, consistent with the syndemic 
theory [55].
We observed parallel reductions in sexual risk behaviors among those in the treatment and 
control conditions in the overall sample, which is consistent with other behavioral 
interventions developed for SUMSM [41, 56]. Some reduction in sexual risk behavior in the 
control arm would have been expected due to regression to the mean, yet it is reassuring that 
SUMSM in the control arm also reduced their risk behavior when provided with rapid HIV 
testing and brief counseling. While there have been intervention trials for SUMSM that have 
shown reductions in sexual risk overall, these studies randomized participants to different 
active treatment conditions (i.e., no passive control arm) [57, 58]. To our knowledge only 
one behavioral intervention significantly increased safer sex behaviors among SUMSM 
compared to a minimal control group [59]; however, that study was limited to HIV-positive 
methamphetamine-using MSM. Thus, no behavioral interventions developed for HIV-
negative SUMSM have shown efficacy in reducing sexual risk behaviors against a passive 
control condition, highlighting the limited effectiveness of stand-alone behavioral 
interventions and the importance of developing combination intervention approaches for 
SUMSM. Future studies are encouraged to develop and evaluate multi-modal interventions 
for HIV risk reduction, including combination counseling and pharmacologic interventions 
[60].
Limitations to the study should be acknowledged. Outcome data were by self-report, 
although ACASI was used to limit the social desirability bias. In addition, our sample was 
limited to SUMSM from San Francisco and our findings may not generalize to other 
locations. As discovered in the analysis, 42 % of the sample screened as dependent on 
substances according to the SDS, and the inclusion of substance-dependent men reduced our 
ability to detect significant intervention effects in the overall sample. However, enrolling 
both dependent and non-dependent episodic SUMSM provided the critical insight that this 
brief counseling intervention is unlikely to be effective for substance-dependent men. Future 
research of SUMSM should aim to more rigorously determine the degree of substance 
dependence prior to enrollment. In addition, the sample size of the subgroup analyses was 
small, and findings should be viewed as preliminary.
Conclusion
This study demonstrated that the adapted PCC intervention was efficacious in reducing 
sexual risk behavior among non-dependent, HIV-negative SUMSM, in particular non-
dependent men of color. As the HIV epidemic in the USA continues to dramatically and 
disproportionately affect MSM and episodic SUMSM remain at high risk for HIV infection 
[25], there is a critical need to develop and evaluate interventions that address multiple 
facets of risk behavior. Combination approaches for SUMSM are needed to modify high-
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risk behavior, especially when under the influence of drugs and alcohol, and increase 
awareness for effective substance use treatment.
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Flow diagram of Project ECHO participant enrollment, allocation, and retention, San 
Francisco, 2010–2012 Legend: PCC personalized cognitive counseling, ITT intent to treat, 
SDS severity of dependence scale
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Unprotected anal intercourse with three most recent non-primary partners among non-
dependent substance-using MSM (N = 186) by treatment arm, Project ECHO, San 
Francisco, 2010–2012 Legend: UAI unprotected anal intercourse, PCC personalized 
cognitive counseling
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Table 1
Most common self-justifications endorsed by PCC arm participants at baseline and 3-month follow-up
Self-justification













Part of me is saying this is risky, but another part is telling me to go for it 130 42 39
Alcohol and/or drugs make it easier to have sex (or different kinds of sex) 125 44 38
This feels more natural. Sex is just better without condoms 107 40 33
He said he was negative, and I have been tested. So it must be safe 106 38 26
I drank/used more than I’d planned and it just happened 106 21 21
I didn’t want to fuck without a condom but the alcohol and/or drugs made me so horny I did it 
anyway
104 27 20
Topping isn’t that risky 100 37 33
I didn’t intend to have sex without a condom, but I was too fucked up and I couldn’t think 
properly
95 28 16
This guy is really into me. It feels good to be wanted so much 90 29 22
He would have told me if he were positive 87 22 18
Condoms take all the feeling away 85 27 21
I’m still negative and I’ve done this before so it can’t be that risky 83 33 25
Sex is better when I am drunk or high 80 30 26
All the alcohol and/or drugs have made me so horny, I just need to fuck 80 23 17
I know enough about this guy, I figure I can trust him 79 28 16
a
Number of participants who completed 3-month self-justification elicitation instruments and persistently endorsed the respective self-justification 
at baseline and 3-month visit
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Table 2











  Age, mean (SD) 33.2 (9.6) 34 (10.5) −0.58 0.56
  Race/ethnicity 3.68 0.45
    White 71 (44) 82 (51)
    Black 14(9) 17(11)
    Latino/Hispanic 48 (29) 38 (24)
    Asian and Pacific 21 (13) 14(9)
  Islander
    Other 9(6) 10(6)
  Country of birth 0.61 0.44
    United States 137 (84) 130 (81)
    Outside United 26 (16) 31 (19)
  States
  Education 1.49 0.48
    High school or less 22 (14) 15(9)
    Some college 114 (70) 116(72)
    College or above 27 (17) 30 (19)
  Income 2.23 0.52
    Under $20,000 44 (27) 52 (32)
    $20,000–9,999 62 (38) 59 (37)
    $50,000–99,999 32 (20) 33 (21)
    $100,000 or above 25 (15) 17(11)
  Employment status 0.004 0.95
    Not employed 41 (25) 40 (25)
    Employed 122 (75) 121 (75)
HIV test history and medical
  Last HIV test 4.73 0.09
    Less than 1 year 150 (92) 148 (92)
    Over 1 year ago 13(8) 9(6)
    Never 0(0) 4(2)
  Has regular health provider 105 (64) 98 (61) 0.44 0.51
  Insurance 1.14 0.57
    No insurance 52 (32) 52 (32)
    Private insurance 91 (56) 83 (52)
    Public insurance 20 (12) 26 (16)
Self-reported substance use, past 3 months
  Methamphetamine 17 (10) 15(9) 0.11 0.74
  Poppers 66 (40) 71 (44) 0.43 0.51























  Cocaine (powdered or crack) 60 (37) 51 (32) 0.95 0.33
  Binge-drinking (5 or more drinks on a single occasion) 149 (91) 142 (88) 0.91 0.34
a
Wilcoxon ranksum z test statistic for age; Chi square test statistic for categorical variables
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